Pre-existing diabetes and lung cancer prognosis
- PMID: 27195423
- PMCID: PMC4931364
- DOI: 10.1038/bjc.2016.141
Pre-existing diabetes and lung cancer prognosis
Abstract
Background: The aims of this study are to investigate the impact of pre-existing diabetes and diabetes treatments on lung cancer prognosis.
Methods: A total of 2484 women with confirmed incident lung cancer from the Women's Health Initiative were followed for an average of 2.9 years through the date of death or 29 August 2014.
Results: Compared with women with lung cancer but without diabetes, women with lung cancer and diabetes had significantly increased risk of overall mortality (HR=1.27, 95% CI: 1.07-1.50). Women with diabetes receiving insulin or metformin or women who had long duration of diabetes also had increased risk of overall mortality.
Conclusions: Our large prospective study provides evidence that pre-existing diabetes is associated with poor overall survival among women with lung cancer, but do not support the hypothesis that metformin use may have a protective effect in women with lung cancer and diabetes.
References
-
- Algire C, Zakikhani M, Blouin MJ, Shuai JH, Pollak M (2008) Metformin attenuates the stimulatory effect of a high-energy diet on in vivo LLC1 carcinoma growth. Endocr Relat Cancer 15(3): 833–839. - PubMed
-
- De Giorgio R, Barbara G, Cecconi A, Corinaldesi R, Mancini AM (2000) Diabetes is associated with longer survival rates in patients with malignant tumors. Arch Intern Med 160(14): 2217–2217. - PubMed
-
- Fine JP, Gray RJ (1999) A proportional hazards model for the subdistribution of a competing risk. J Am Stat Assoc 94(446): 496–509.
-
- Garcia-Jimenez C, Garcia-Martinez JM, Chocarro-Calvo A, De la Vieja A (2014) A new link between diabetes and cancer: enhanced WNT/beta-catenin signaling by high glucose. J Mol Endocrinol 52(1): R51–R66. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical